Growth Metrics

Nu-Med Plus (NUMD) Return on Invested Capital (2016 - 2019)

Nu-Med Plus recorded quarterly Return on Invested Capital of 0.04% in Q3 2019, down 34.08% quarter-over-quarter from 0.06% in Q2 2019.

Nu-Med Plus' Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.04% for Q3 2019.

  • In Q3 2019, Return on Invested Capital changed N/A year-over-year to 0.04%; the TTM figure through Sep 2019 stood at 0.04% (changed N/A YoY), while the FY2018 annual figure was 0.17%, changed N/A from the prior year.
  • Return on Invested Capital came in at 0.04% for Q3 2019 at Nu-Med Plus, down from 0.06% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.18% in Q1 2019 to a low of 0.37% in Q3 2017.
  • A 4-year average of 0.02% and a median of 0.0% in 2016 frame the typical range for Return on Invested Capital.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.00%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.00%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.00%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.00%
10 Nu-Med Plus - - - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2019 0.04%
Jun 30, 2019 0.06%
Mar 31, 2019 0.18%
Dec 31, 2018 -0.09%
Sep 30, 2017 -0.37%
Jun 30, 2017 -0.01%
Mar 31, 2017 0.00%
Dec 31, 2016 0.00%